ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agre…

Read More

Drop your comments

Click to Comment

Share this post with your friends on


COMMENTS (0)

Reply

All fields are required

Save my name for the next time I comment